Transient Neurologic Symptoms following spinal Lignocaine and Bupivacaine for caesarean delivery at Mulago Hospital, a randomised trial.

Transient Neurologic symptoms following spinal lignocaine and bupivacaine for caesarean delivery in mulago hospital, a randomised trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201306000510382

Enrollment

180

Registered

2013-02-26

Start date

2013-03-20

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases its comparing safety profile for the different drugs in the randomised trial.

Interventions

Lignocaine

Bupivacaine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: only ASA 1 and 2 and E , patients above 18 and provide informed consent to participate in the study will be enrolled.

Exclusion criteria

Exclusion criteria: Patients with previous neurologic deficits, periperal neuropathy like diabetes, previous back injuries. Failed spinal :patients who receive spinal blockade with either Lignocaine or Bupivacaine, and the drug fails to take, then get general anaesthesia will be excluded.

Design outcomes

Primary

Measure	Time frame
to compare the incidence of transient neurologic symptoms in either bupivacaine or lignocaine arms	—

Secondary

Measure	Time frame
Patients will be asseddes for factors that may contribute to the existence of TNS like needle type, number of attempts at spinal, Age and weight. These will be analysed at the end in either arms of the study. The outcome will be calculated with Poisson distribution	—

Countries

Uganda

Contacts

Public ContactArthur Kwizera

Lecturer

kwizera.arthur@gmail.com+256-772-897171

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026